Medical Necessity for Inpatient Services (2026 Reference Guide)

1. Statutory & Regulatory Definition of Medical Necessity

Medical necessity serves as the foundational threshold for all Medicare and commercial healthcare reimbursement. Under Section 1862(a)(1)(A) of the Social Security Act, no payment may be made under Medicare Part A or Part B for items or services that are:

β€œNot reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.”

CMS Overarching E/M Principle

As reinforced in CMS IOM Pub. 100-04 (Medicare Claims Processing Manual), Chapter 12, Β§ 30.6.1:

  • Medical Decision Making (MDM) scoring or Total Documented Time alone does not automatically entitle a provider to bill a specific Evaluation and Management (E/M) code.
  • The volume and clinical complexity of documentation must match the clinical severity and medical necessity of the patient’s condition.
  • Providing high-volume documentation or billing high-level E/M codes (99223, 99233) for clinically stable, convalescent, or custodial patients constitutes an audit trigger and non-compliant billing.
β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚                   CMS REIMBURSEMENT HIERARCHY                          β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ 1. STATUTORY MEDICAL NECESSITY (SSA Β§ 1862(a)(1)(A))                   β”‚
β”‚    └── The service must be clinically justified and reasonable.        β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ 2. COVERAGE POLICY (NCDs, LCDs, Two-Midnight Rule 42 CFR Β§ 412.3)      β”‚
β”‚    └── Patient status (Inpatient vs. Observation) & covered indicationsβ”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ 3. CPT & E/M GUIDELINES (MDM Level or Cumulative Time Thresholds)      β”‚
β”‚    └── Code selection within the medically necessary framework         β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

2. CMS Two-Midnight Rule (42 CFR Β§ 412.3)

The Two-Midnight Rule governs hospital inpatient admission determinations under Medicare Part A. It establishes objective time-based benchmarks while preserving physician clinical judgment.

                    β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
                    β”‚   PATIENT PRESENTATION AT     β”‚
                    β”‚   EMERGENCY DEPT / CLINIC     β”‚
                    β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                                    β”‚
                                    β–Ό
                    β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
                    β”‚   PHYSICIAN CLINICAL DECISION  β”‚
                    β”‚   Does patient require acute  β”‚
                    β”‚   care spanning β‰₯2 midnights? β”‚
                    β””β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”˜
                            β”‚               β”‚
                  YES (β‰₯ 2 Midnights)    NO (< 2 Midnights)
                            β”‚               β”‚
                            β–Ό               β–Ό
            β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
            β”‚ FORMAL INPATIENT     β”‚  β”‚ OUTPATIENT OBSERVATION STATUS    β”‚
            β”‚ ADMISSION ORDER      β”‚  β”‚ (POS 22)                         β”‚
            β”‚ (Part A / MS-DRG)    β”‚  β”‚ (Part B / OPPS)                  β”‚
            β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                                                     β”‚
                                            Exception Applies?
                                   (IPO List, Death, Transfer, AMA,
                                    Unexpected Clinical Deterioration)
                                                     β”‚
                                           β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
                                         YES                   NO
                                           β”‚                   β”‚
                                           β–Ό                   β–Ό
                                  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β” β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
                                  β”‚ INPATIENT ORDER β”‚ β”‚ MAINTAIN         β”‚
                                  β”‚ (Document       β”‚ β”‚ OBSERVATION      β”‚
                                  β”‚  Justification) β”‚ β”‚ (Issue MOON if   β”‚
                                  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜ β”‚  > 24 Hours)     β”‚
                                                      β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

The Two-Midnight Benchmark vs. Two-Midnight Presumption

ConceptLegal & Regulatory BasisOperational Application
Two-Midnight Benchmark42 CFR Β§ 412.3(a)The admitting practitioner must have a reasonable, documented expectation that the patient will require medically necessary hospital care spanning at least 2 midnights. The clock begins when the patient starts receiving outpatient services (e.g., triage/triage order in the ED or initiation of observation).
Two-Midnight Presumption42 CFR Β§ 412.3(b)Inpatient claims with a length of stay spanning midnights after formal inpatient admission are presumed appropriate for Part A payment and are generally exempt from post-payment medical necessity reviews by Beneficiary and Family-Centered Care Quality Improvement Organizations (BFCC-QIOs) and RACs, absent evidence of systematic gaming or fraud.

Exceptions to the Two-Midnight Benchmark ( Midnights)

Inpatient admission remains payable under Part A for stays lasting less than two midnights under specific, well-documented circumstances:

  1. CMS Inpatient-Only (IPO) List (CY 2026 OPPS Addendum E):
    • Surgical procedures designated as inpatient-only (e.g., open aortic reconstructions, major spinal reconstructive fusions, craniotomies) are payable under Part A regardless of whether the stay spans 2 midnights.
  2. Unforeseen Clinical Events:
    • Unexpected patient death.
    • Unexpected rapid clinical improvement where the initial documented expectation was midnights.
    • Unforeseen patient transfer to another acute care hospital or specialized facility.
    • Patient leaves Against Medical Advice (AMA) before the second midnight.
  3. Severe Acute Clinical Instability / Case-by-Case Exception:
    • Initiation of invasive mechanical ventilation during an acute crisis.
    • Clinical complexity requiring aggressive, intensive inpatient monitoring where the physician explicitly documents why outpatient observation was unsafe or inappropriate.

Medicare Advantage (MA) 2024–2026 Rule (CMS-4201-F)

Under CMS-4201-F regulations:

  • Medicare Advantage plans (Part C) must adhere to traditional Medicare Two-Midnight rules, the Inpatient-Only (IPO) list, and National/Local Coverage Determinations (NCDs/LCDs).
  • MA plans are prohibited from using proprietary commercial guidelines (such as InterQual or MCG) to deny inpatient Part A coverage when the patient clinically meets the CMS 2-midnight standard.

3. Inpatient vs. Observation: Coding & Financial Architecture

Observation care is an outpatient hospital service furnished while the physician evaluates whether the patient needs formal inpatient admission or can be safely discharged.

Consolidated E/M Code Sets (2023–2026 Policy)

The AMA and CMS unified the observation and inpatient E/M code families. Separate observation codes (formerly 99217–99220) are permanently deleted.

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚                      2026 INPATIENT & OBSERVATION E/M CODE MATRIX                       β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ Clinical Service Type β”‚ CPT Code Range                β”‚ Facility Place of Service (POS) β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Initial Care**      β”‚ [[99221]], [[99222]], [[99223]] β”‚ POS 21 (Inpatient) / POS 22 (Obs)β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Subsequent Care**   β”‚ [[99231]], [[99232]], [[99233]] β”‚ POS 21 (Inpatient) / POS 22 (Obs)β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Same-Day Admit/DC** β”‚ [[99234]], [[99235]], [[99236]] β”‚ POS 21 (Inpatient) / POS 22 (Obs)β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Discharge Service** β”‚ [[99238]], [[99239]]          β”‚ POS 21 (Inpatient) / POS 22 (Obs)β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Consultations**     β”‚ [[99252]], [[99253]], [[99254]], [[99255]] β”‚ Commercial Payers (Non-Medicare)β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

Inpatient vs. Observation Comparison Matrix

Operational DimensionInpatient Hospital Status (POS 21)Observation Outpatient Status (POS 22)
Legal / StatusFormally admitted under physician orderOutpatient receiving observation services
Facility ReimbursementMedicare Part A: MS-DRG prospective payment systemMedicare Part B / OPPS: APC bundled ambulatory payment
ProFee Billing99221–99239 with POS 2199221–99239 with POS 22
Admitting Modifier-AI appended to initial care by admitting MD-AI appended by primary attending of record
Patient Financial LiabilityPart A deductible ($1,600+) for benefit period; no copay for days 1–60Part B 20% coinsurance + individual copayments for labs, radiology, and IV meds
SNF Stay Qualification3 consecutive inpatient midnights qualify patient for Part A SNF benefitObservation midnights do not count toward SNF 3-day qualifying stay
Mandatory NoticeImportant Message from Medicare (IM / CMS-10065)MOON Notice (CMS-10611) if observation hours

4. Utilization Review, Condition Code 44, & Required Notices

Condition Code 44 (Inpatient to Outpatient Conversion)

When a hospital’s Utilization Review Committee (URC) or Physician Advisor determines upon chart review that an inpatient admission does not meet medical necessity criteria, the hospital may convert the stay to outpatient observation using Condition Code 44 only if all four CMS regulatory criteria are met prior to discharge:

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚                   CONDITION CODE 44: MANDATORY CRITERIA                β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ 1. Change is made PRIOR TO DISCHARGE and while patient is in facility. β”‚
β”‚ 2. Hospital has NOT submitted a claim to Medicare under Part A.        β”‚
β”‚ 3. The URC or Physician Advisor concurs with the status change.         β”‚
β”‚ 4. The attending physician concurs (or URC makes final determination   β”‚
β”‚    after opportunity for attending consultation).                      β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
  • Claim Submission: The entire hospital stay is billed on an Outpatient Type of Bill (TOB 131) with Condition Code 44.
  • Part B Inpatient Rebilling (TOB 121 / Condition Code W2): If the patient has already been discharged before the status error was identified, Condition Code 44 cannot be used. The hospital must submit a Part A no-pay claim (TOB 110) and may rebill allowable Part B inpatient ancillary services within the 1-year timely filing limit (TOB 121).

Mandatory Beneficiary Notices

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚                           MANDATORY BENEFICIARY NOTICES                                 β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ Notice Type           β”‚ Form CMS Number               β”‚ Timing & Delivery Trigger       β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **MOON**              β”‚ **CMS-10611**                 β”‚ Delivered within **36 hours** ofβ”‚
β”‚ (Medicare Outpatient  β”‚                               β”‚ receiving observation services; β”‚
β”‚ Observation Notice)   β”‚                               β”‚ explains outpatient status and  β”‚
β”‚                       β”‚                               β”‚ Part B cost sharing.            β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Important Message** β”‚ **CMS-10065**                 β”‚ Delivered within **2 days of    β”‚
β”‚ **from Medicare (IM)**β”‚                               β”‚ admission**, and follow-up copy β”‚
β”‚                       β”‚                               β”‚ delivered within 2 days of DC.  β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **HINN 10 / HINN 11** β”‚ **HINN (Hospital-Issued**     β”‚ Delivered when inpatient care isβ”‚
β”‚ (Notice of Review &   β”‚ **Notice of Noncoverage)**    β”‚ determined not medically        β”‚
β”‚ Noncoverage)          β”‚                               β”‚ necessary (pre/during stay).    β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

5. Commercial Payers, Screening Criteria (MCG & InterQual), & P2P Appeals

Commercial payers and Medicare Advantage plans deploy automated utilization management algorithms and clinical screening criteria:

MCG (Milliman Care Guidelines) & InterQual Criteria

  • Severity of Illness (SI): Evaluates physiological instability, abnormal vital signs, high-risk laboratory/imaging markers, and functional decline.
  • Intensity of Service (IS): Evaluates treatments requiring inpatient resources (continuous IV vasopressors, telemetry, surgical interventions, frequent blood gas analysis, nursing assessments).

Peer-to-Peer (P2P) Consultation & Appeal Strategies

When a payer issues a concurrent or retrospective denial of inpatient status:

  1. Act Within the P2P Window: Most commercial payers require a Peer-to-Peer discussion within 24 to 48 hours of verbal/electronic denial notification.
  2. Clinical Framing Technique:
    • Do Not Rely on Vague Terms: Avoid stating β€œpatient required monitoring” or β€œpatient was too weak to go home.”
    • Emphasize Active Interventions: Detail dynamic medication titration (e.g., β€œtitrating IV furosemide due to flash pulmonary edema unresponsive to oral regimens”).
    • Highlight Diagnostic Instability: Detail the continuous risk of catastrophic deterioration (e.g., β€œunstable troponin leak with high TIMI score requiring urgent cardiac catheterization”).
    • Cite Failure of Outpatient Therapy: Document that oral antibiotics, outpatient clinic management, or ED observation failed to stabilize the condition.

6. ProFee E/M Medical Necessity Compliance (Part B)

Professional fee billing requires independent clinical justification for each billed encounter.

Medical Necessity by Encounter Type

Encounter TypeCPT CodesMedical Necessity Documentation Standards
Initial Hospital Care99221–99223Detailed history of presenting illness, baseline comparison, differential diagnosis, acute risk stratification, and clear documentation of why hospital-level care is required.
Subsequent Hospital Care99231–99233Daily medical necessity is required. Must document daily response to therapy, changes in vital signs/labs, modification of treatment plan, and rationale for continuing hospital stay. Billing 99233 on stable patients awaiting placement constitutes non-compliant coding.
Same-Day Admit & Discharge99234–99236Stays spanning hours on the same calendar date. Must document two separate, distinct evaluations (initial evaluation and final discharge assessment) with continuous active management.
Discharge Services99238–99239Final physical examination, medication reconciliation, multidisciplinary instructions, coordination with post-acute providers, and total cumulative time documented if billing 99239 ( min).
Inpatient Consultations99252–99255Explicit written request from the attending physician specifying a distinct clinical question; comprehensive specialist report returned to the medical record (β€œ3 R’s”).
Critical Care99291, 99292Imminent life-threatening deterioration of one or more vital organ systems requiring direct, active decision-making. Minimum 30 minutes of non-procedural physician time.

7. High-Risk Clinical Inpatient Admission Scenarios

The following clinical conditions represent primary targets for RAC audits, MAC pre-payment reviews, and commercial medical necessity denials. Clinical documentation must include objective clinical criteria and aggressive therapeutic interventions:

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚                     HIGH-RISK INPATIENT ADMISSION CLINICAL TARGETS                       β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ Clinical Condition    β”‚ ICD-10 Diagnosis Codes        β”‚ Key Medical Necessity Markers    β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Sepsis / Sepsis-3** β”‚ [[A41.9]], [[R65.20]]         β”‚ SOFA score $\ge 2$ drop; acute   β”‚
β”‚                       β”‚                               β”‚ organ dysfunction (AKI, ARF,     β”‚
β”‚                       β”‚                               β”‚ thrombocytopenia, altered mental β”‚
β”‚                       β”‚                               β”‚ status); IV fluid boluses ($30$  β”‚
β”‚                       β”‚                               β”‚ mL/kg); blood cultures prior to  β”‚
β”‚                       β”‚                               β”‚ broad-spectrum IV antibiotics.   β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Acute Respiratory** β”‚ [[J96.01]] (Hypoxemic),       β”‚ $PaO_2 < 60$ mmHg, $SpO_2 < 91\%$β”‚
β”‚ **Failure (ARF)**     β”‚ [[J96.02]] (Hypercapnic),     β”‚ on room air, $PaCO_2 > 50$ mmHg  β”‚
β”‚                       β”‚ [[J96.00]] (Unspecified)      β”‚ with $pH < 7.35$; tachypnea      β”‚
β”‚                       β”‚                               β”‚ ($RR > 28$), accessory muscle    β”‚
β”‚                       β”‚                               β”‚ use; High-flow nasal cannula,    β”‚
β”‚                       β”‚                               β”‚ BiPAP/CPAP, or mechanical vent.  β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Acute Kidney**      β”‚ [[N17.9]], [[N17.0]] (ATN)    β”‚ KDIGO criteria: $\ge 0.3$ mg/dL  β”‚
β”‚ **Injury (AKI)**      β”‚                               β”‚ rise in $Cr$ in 48h or $\ge 1.5$ β”‚
β”‚                       β”‚                               β”‚ baseline; oliguria $< 0.5$ mL/kg/β”‚
β”‚                       β”‚                               β”‚ hr for $> 6$h; nephrology consultβ”‚
β”‚                       β”‚                               β”‚ and aggressive IV hydration.     β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Acute Decompensated**β”‚ [[I50.23]] (Systolic),       β”‚ Elevated NT-proBNP / BNP; new    β”‚
β”‚ **Heart Failure**     β”‚ [[I50.33]] (Diastolic),       β”‚ bilateral pulmonary crackles or  β”‚
β”‚                       β”‚ [[I50.43]] (Combined)         β”‚ edema; continuous telemetry;     β”‚
β”‚                       β”‚                               β”‚ high-dose IV loop diuretics;     β”‚
β”‚                       β”‚                               β”‚ echocardiogram $EF$ monitoring.  β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **NSTEMI / Acute MI** β”‚ [[I21.4]] (Type 1 NSTEMI),    β”‚ Dynamic rise/fall of cardiac     β”‚
β”‚                       β”‚ [[I21.A1]] (Type 2 Infarct)   β”‚ troponins above 99th percentile; β”‚
β”‚                       β”‚                               β”‚ ischemic ECG changes; telemetry; β”‚
β”‚                       β”‚                               β”‚ IV heparin/enoxaparin; urgent    β”‚
β”‚                       β”‚                               β”‚ cardiac catheterization.         β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Acute Toxic /**     β”‚ [[G93.41]] (Metabolic),       β”‚ Acute change from baseline mentalβ”‚
β”‚ **Metabolic**         β”‚ [[G93.40]] (Encephalopathy)   β”‚ status; CAM-ICU positive; safety β”‚
β”‚ **Encephalopathy**    β”‚                               β”‚ 1:1 supervision; treatment of    β”‚
β”‚                       β”‚                               β”‚ underlying toxin/infection/organ β”‚
β”‚                       β”‚                               β”‚ failure (avoid "altered mental").β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ **Severe Electrolyte**β”‚ [[E87.1]] (Hyponatremia),     β”‚ Symptomatic sodium $< 120$ mEq/L β”‚
β”‚ **Derangement**       β”‚ [[E87.5]] (Hyperkalemia)      β”‚ or potassium $> 6.0$ mEq/L;      β”‚
β”‚                       β”‚                               β”‚ continuous ECG telemetry; $q2-4h$β”‚
β”‚                       β”‚                               β”‚ lab monitoring; IV 3% saline or  β”‚
β”‚                       β”‚                               β”‚ insulin/glucose/calcium chloride.β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

8. Auditor-Proof Medical Necessity Documentation Checklist

Use this checklist during clinical chart reviews and coding compliance audits to ensure medical necessity defensibility:

β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
β”‚               INPATIENT MEDICAL NECESSITY AUDIT CHECKLIST              β”‚
β”œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€
β”‚ [ ] 1. VALID ADMISSION ORDER: Written, dated, timed, and authenticated β”‚
β”‚        by an authorized provider prior to discharge.                   β”‚
β”‚ [ ] 2. 2-MIDNIGHT BENCHMARK DOCUMENTATION: Explicit documentation of   β”‚
β”‚        the physician's clinical expectation of a β‰₯2-midnight stay.     β”‚
β”‚ [ ] 3. STATUS VERIFICATION: Verified POS 21 (Inpatient) vs. POS 22     β”‚
β”‚        (Observation) matches the patient's actual administrative status.β”‚
β”‚ [ ] 4. SEVERITY OF ILLNESS (SI): Objective vital sign instability,     β”‚
β”‚        lab abnormalities, and physical exam findings documented.       β”‚
β”‚ [ ] 5. INTENSITY OF SERVICE (IS): Clear rationale for hospital-level   β”‚
β”‚        therapies (IV drips, continuous telemetry, surgical evaluation).β”‚
β”‚ [ ] 6. DAILY PROGRESSIVE CLINICAL UPDATES: Daily progress notes        β”‚
β”‚        demonstrate ongoing acute medical necessity (no cloned notes).  β”‚
β”‚ [ ] 7. CDI & SPECIFICITY: Avoided vague symptoms ("chest pain",        β”‚
β”‚        "altered mental status") in favor of specific definitive        β”‚
β”‚        diagnoses ([[I21.4]], [[G93.41]], [[A41.9]]).                   β”‚
β”‚ [ ] 8. ADMITTING MODIFIER [[-AI]]: Appended exclusively to initial     β”‚
β”‚        hospital care by the principal admitting physician of record.   β”‚
β”‚ [ ] 9. NOTICE COMPLIANCE: MOON notice (CMS-10611) delivered if         β”‚
β”‚        observation spanned > 24 hours.                                 β”‚
β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

Inpatient ProFee & E/M Resources

Regulatory, Guidelines, & Audit Compliance

Modifiers & Reimbursement Rules

  • -AI β€” Principal Physician of Record Attending Identifier
  • -FS β€” Split/Shared Evaluation & Management Encounters
  • -GC β€” Teaching Physician Presence & Resident Supervision Rules
  • -25 β€” Significant, Separately Identifiable E/M Encounter on the Day of a Procedure
  • -57 β€” Decision for Major Surgery During an Evaluation Encounter